Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

Johnson & Johnson (JNJ) is attracting investor attention, with shares down 1.6% over the past month compared to a 0.6% gain for the S&P 500. JNJ's current quarter EPS is projected to be $2.65, a 6% year-over-year decrease, while revenue is estimated at $22.77 billion, a 1.4% increase; full-year EPS is expected to rise 6.2% to $10.6, with revenue up 2.7% to $91.19 billion, and the stock currently holds a Zacks Rank #3 (Hold), suggesting near-term performance in line with the market.

Analysis

Johnson & Johnson (JNJ) has recently garnered significant investor attention despite its shares underperforming the broader market, returning -1.6% over the past month compared to the S&P 500 composite's +0.6% gain and a +3.7% gain for the Zacks Large Cap Pharmaceuticals industry. Near-term earnings projections indicate a mixed outlook: the current quarter's earnings are expected at $2.65 per share, a 6% decrease year-over-year, though the consensus estimate has remained stable for the last 30 days. Conversely, full-year earnings for the current fiscal year are projected at $10.60 per share, representing a 6.2% increase from the prior year, with next fiscal year's earnings anticipated to grow by a further 3.5% to $10.98 per share; these annual estimates have also been static for the past month. Revenue forecasts show modest growth, with current quarter sales estimated at $22.77 billion (+1.4% YoY), current fiscal year sales at $91.19 billion (+2.7% YoY), and next fiscal year sales at $94.24 billion (+3.4% YoY). JNJ's last reported quarterly results were strong, with revenues of $21.89 billion (+2.4% YoY) and EPS of $2.77, surpassing consensus estimates by +1.26% and +7.78% respectively, and extending a trend of beating both revenue and EPS estimates for the trailing four quarters. The stock holds a Zacks Rank #3 (Hold), suggesting it may perform in line with the market in the near term, and is graded B for Value, indicating it trades at a discount relative to its peers.

Key Decisions for Investors

• Given the Zacks Rank #3 (Hold) and stable earnings estimates amidst recent share price underperformance, investors might consider maintaining current positions while monitoring for any shifts in earnings estimate revisions, which are highlighted as key stock price drivers.
• The contrast between a projected current-quarter EPS decline of 6% and expected full-year EPS growth of 6.2%, alongside consistent past earnings beats, suggests a need to evaluate near-term headwinds against longer-term operational strength.
• With a Value Style Score of B, indicating a potential discount to peers, JNJ could present a relative value opportunity, though this should be weighed against modest near-term revenue growth forecasts of 1.4% for the current quarter and 2.7% for the full year.